Rayasal (salicylic acid)
Topical Cream (Gram)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Salicylic acid is a keratolytic agent.
Salicylic acid is used topically for its keratolytic effect in the management of acne and other skin conditions such as seborrheic dermatitis, psoriasis, and dandruff; the drug also is used topically for the removal of warts, corns, and calluses.
Generic name: salicylic acid
Therapeutic class: Dermatological
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Rayasal
Indications
The following indications are listed for Rayasal:
- Acne Vulgaris
- Dandruff
- Keratoderma
- Psoriasis
- Seborrheic Dermatitis
Also known as: Acne Simplex, Branny Tetter, Common Acne, Dermatitis Seborrheica, Dyssebacea, Dyssebacia, Pityriasis Capitis, Pityriasis Sicca, Pityriasis Simplex, Scurf, Seborrhea Corporis, Seborrhea Furfuracea, Seborrhea Sicca, Seborrheic Eczema, Simple Acne, Unna's Disease.
Dosing
No dosing information is available for this tab.
Salicylic acid is applied topically to the skin as a cake, cream, gel, lotion, ointment, pledget, plaster, shampoo, solution, or suspension. Topical preparations of salicylic acid are for external use only. Contact with the eyes should be avoided; if contact occurs, the affected eye(s) should be washed thoroughly with water.
Prior to topical application, the affected area(s) to be treated should be cleansed and allowed to dry. Prior to removal of warts, corns, and calluses, the affected area may be soaked in warm water for 5 minutes.
Salicylic acid is commercially available in various preparations, some of which are intended for self-medication; the manufacturer's product labeling should be consulted for complete directions regarding appropriate dosage and administration of specific products.
| Drug label | Dosing type | Instructions |
|---|---|---|
| Rayasal 5.9% Cream | Maintenance | Apply to the clean, dry affected area(s) by topical route 2 times perday and rub in until completely absorbed. |
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Aspirin exacerbated respiratory disease
- Hemolytic anemia from pyruvate kinase and g6PD deficiencies
There are no severe contraindications for this drug.
- Peripheral vascular disease
Adverse reactions
There is no enhanced messaging for this drug.
Rare or Very Rare
- Anaphylaxis
- Burns
- Dyspnea
- Facial edema
- Hypersensitivity drug reaction
- Periorbital edema
- Pharyngeal edema
- Skin ulcer
- Superficial skin ulcer
- Syncope
- Throat constriction
- Urticaria
More Frequent
- Stinging of skin
Less Frequent
- Dry skin
- Skin irritation
Rare or Very Rare
- Pruritus of skin
Precautions
No enhanced messaging available.
No enhanced messaging available.
There are no adequate and well-controlled studies of topical salicylic acid in pregnant women; the drug should be used during pregnancy only if the potential benefits justify the possible risks to the fetus.
Because of the potential for serious adverse reactions to salicylic acid in nursing infants, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the woman. If used in nursing women, the drug should not be applied to the chest area to avoid accidental contamination of the infant.
No enhanced messaging available.
ICD codes
| Code | Type | Description |
|---|---|---|
| Acne vulgaris | ||
| L70.0 | ICD10CM | Acne vulgaris |
| Dandruff | ||
| L21.0 | ICD10CM | Seborrhea capitis |
| Keratoderma | ||
| L85.1 | ICD10CM | Acquired keratosis [keratoderma] palmaris et plantaris |
| Psoriasis | ||
| L40 | ICD10CM | Psoriasis |
| L40.0 | ICD10CM | Psoriasis vulgaris |
| L40.1 | ICD10CM | Generalized pustular psoriasis |
| L40.2 | ICD10CM | Acrodermatitis continua |
| L40.3 | ICD10CM | Pustulosis palmaris et plantaris |
| L40.4 | ICD10CM | Guttate psoriasis |
| L40.5 | ICD10CM | Arthropathic psoriasis |
| L40.50 | ICD10CM | Arthropathic psoriasis, unspecified |
| L40.51 | ICD10CM | Distal interphalangeal psoriatic arthropathy |
| L40.52 | ICD10CM | Psoriatic arthritis mutilans |
| L40.53 | ICD10CM | Psoriatic spondylitis |
| L40.54 | ICD10CM | Psoriatic juvenile arthropathy |
| L40.59 | ICD10CM | Other psoriatic arthropathy |
| L40.8 | ICD10CM | Other psoriasis |
| L40.9 | ICD10CM | Psoriasis, unspecified |
| Seborrheic dermatitis | ||
| L21 | ICD10CM | Seborrheic dermatitis |
| L21.0 | ICD10CM | Seborrhea capitis |
| L21.1 | ICD10CM | Seborrheic infantile dermatitis |
| L21.8 | ICD10CM | Other seborrheic dermatitis |
| L21.9 | ICD10CM | Seborrheic dermatitis, unspecified |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.